Conference Coverage

Pain remains after rheumatoid arthritis diagnosis


 

REPORTING FROM THE EULAR 2018 CONGRESS

SOURCE: Lee YC et al. EULAR 2018 Congress.Abstract OP0349.

Pages

Recommended Reading

FDA advisory committee votes to recommend update to celecoxib safety labeling
MDedge Family Medicine
Methotrexate-induced pulmonary fibrosis risk examined in 10-year study
MDedge Family Medicine
Disease burden higher in osteoarthritis than rheumatoid arthritis
MDedge Family Medicine
Long-term follow-up most important for hydroxychloroquine retinal screening
MDedge Family Medicine
Malignancy risk of tocilizumab and TNF inhibitors found similar
MDedge Family Medicine
Functional disability prevails despite rheumatoid arthritis treatment
MDedge Family Medicine
NIH cans study that relied on millions in funding from alcohol companies
MDedge Family Medicine
TNF inhibitor linked to one-third drop in total mortality
MDedge Family Medicine
Severe OA sparks depression, surgery “ameliorates” depression in RA
MDedge Family Medicine
Heart failure confers poor prognosis in rheumatoid arthritis
MDedge Family Medicine